Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
You have a life, goals, and a desire to help others
Eryptosis-associated kinases Intracellular signaling of eryptosis has been extensively studied, and many important protein kinases implicated in the regulation of various functions of nucleated cells have been demonstrated to control eryptosis
Nanotechnology-based drug delivery for central nervous system disorders
:
US$ 23.20
US$ 22.78
US$ 24.60
US$ 24.16
US$ 22.44
